Recommended
Recommended
More Related Content
Recently uploaded
Recently uploaded (20)
Featured
Featured (20)
Presentasi terapi inhalasi
- 1. INHALA LEBIHJAUH Dr Salim S Thalib
- 2. INHALASI OBAT MEL. SAL. NAPAS BENTUK AEROSOL TUJUAN TERAPI LOKAL DAN SISTEMIK DEFINISI
- 3. INHALASI MANFAAT DOSIS RENDAH EFEK SAMPING MINIMAL ONSET CEPAT
- 4. INHALASI
- 5. INHALASI
- 11. TINGGI RENDAH INHALASI LAMA MINIMAL KHASIAT OBAT EFEK SISTEMIK PENYERAPAN ORAL PLASMA PROTEIN
- 16. INHALASI DEPOSISI AEROSOL PADA PARU NASOPHARENGEAL IMPACTION TRACHEOBRONCHIAL IMPACTION (CENTRAL) SEDIMANTATION PULMONARY SEDIMANTATION DIFFUSION (PERIPHERAL)
- 17. INHALASI UKURAN AEROSOL MEDIAN DIAMETER-MICROMETERMASS MEDIAN DIAMETER- MICROMETER DEPOSITIONFRACTION
- 18. INHALASI KECEPATAN AEROSOL TEND TO GET TEND TO SLOWER FLOW DEPOSITED IN UPPER AIRWAY MINIMIZED UPPER AIRWAY ENHANCHES DISTAL DELIVERY HIGH VELOCITY LOW VELOCITY DEPOSITION
- 19. DEPOSITION DEPOSITION INHALASI TIPE PERNAPASAN BREATH HOLD AT END INSPIRATION INCREASED CENTRAL RAPID INHALATION SLOW INHALATION INCREASED PERIPHERAL
- 20. INHALASI ABSORPTION ABSORPTION TIPE PERNAPASAN LOW SYSTEMIC IMPACTION VASCULER BED HIGH SYSTEMIC HUMIDIFICATION NASAL BREATHING MOUTH BREATHING
- 21. INHALASI PENETRASI OBAT SMALL AIRWAY MORE DEPOSITION NARROWING AIRWAY : VARIASI NORMAL JALAN NAPAS PENYAKIT DASAR PARU KEDALAMPARU BRONCHOSPAM, FIBROTIC, SECRET MORE DEPOSITION IN CENTRAL Martonen TK , Pharm Respir 1995, 12: 96 IN CENTRAL
- 22. INHALASI PENETRASI OBAT KEDALAMPARU ADULT CHILD CHILD WITH INFLAMED AIRWAY
- 23. INHALASIFACTORS AFFECTING DELIVERY OF AEROSOLIZED TO THE LUNG FACTORSAFFECTINGDELIVERY
- 24. INHALASI HASIL TERAPI MELALUI EFEK TOPIKAL PROSES ABSORBSI GABUNGAN
- 25. INHALASI H.derendorf, Eur J 2006 ; 28 1042-1050 On site activation in the lung. low oropharyngeal exposure. Negligible oral bioavallability. protein binding and rapid clearance Decrease local and systemic side effects small particle High receptor binding activity. long pulmonary residence time. Lipid conjugation. Increase or prolong the anti inflammatory effects PHARMACOKINETIC PHARMACODYNAMIC
- 29. INHALASI PERANAN TERAPI INHALASI PENYAKIT PARU PERANANTERAPIINHALASIPADAPENYAKITPARU PCP
- 37. PMETERED DOSE INHALERSHow to use PRESSURIZED
- 41. INHALASI PMETERED DOSE INHALERS SPACER DEVICES PRESSURIZED EFFECT OF DIAMETER AND SPACER LENGTH ON AVAILABILITY OF DRUG
- 42. INHALASIWHY USE A WITH AN INHALER INHALER ALONE, INHALER WITH SPACER, MEDICINE ENDS UP IN MORE MEDICINE IS THE MOUTH, THROAT,STOMACH AND DELIVERED TO THE
- 43. DEVICES PMETERED DOSE INHALERS SPACER DEVICES 3 CATEGORIES : SIMPLE TUBE HOLDING CHAMBER RESERVE - FLOW PRESSURIZED
- 44. PMETERED DOSE INHALERS SIMPLE TUBE SIMPLE TUBE EXTENTION PRESSURIZED TO ACTUATOR SPACER MOUTHPIECE
- 45. PMETERED DOSE INHALERS VALVE HOLDING PRESSURIZED CHAMBER
- 46. PMETERED DOSE INHALERS VALVE HOLDING PRESSURIZED CHAMBER
- 47. PMETERED DOSE INHALERSHow to use PRESSURIZED WITH SPACER P- MDI WITH SPACER
- 53. INHALASI DRY POWDERINHALERS PORTABLE INSPIRATORY FLOW- DRIVEN DEVICES THAT DELIVER POWDER FORMULATIONS OF INHALED DRUG TO LUNG
- 55. INHALASI DRY POWDERINHALERS PRINCIPLES OF DRY POWDER INHALER DESIGN
- 57. INHALASI DRY POWDERINHALERS PERBANDINGAN DEPOSISI OBAT P-MDI 15 % DPI 32 % Thorsson et al, 1998
- 59. INHALASI
- 75. INHALASI
- 76. MIST INHALER
- 77. CHARACTERISTIC OF THE AEROSOL GENERATORS
- 78. •KARAKTERISTIK INHALASIIDEAL OBAT BIAYA TERAPI YANG EKONOMIS DEPOSISI OROPHARYNX RENDAH DEPOSISI PARU TINGGI NYAMAN, KOORDINASI MINIMAL
- 79. INHALA KE ALI LEBIHJAUH Dr Salim S Thalib